SB
Samsara BioCapital, L.P. disclosed a 9.9% stake in VTVT
Samsara BioCapital, L.P. reported owning 9.9% of vTv Therapeutics Inc. (VTVT) (412,654 shares) in a Schedule 13D filed Nov 16, 2026.
A 13D means the holder may push for changes at the company.